Kalvista Pharmaceuticals Inc (KALV)

Sales/Maturities of Investments

$34.88M

TTM · Period ending: · USD

KALV logo

KALV Sales/Maturities of Investments

Latest reported$34.88M
KALV TTM Sales/Maturities of Investments ($0.00 → $34.88M)
High-resolution chart · PNG

KALV sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Kalvista Pharmaceuticals Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
34,882,000
78,584,000
78,061,000
126,937,000
123,490,000
117,793,000
114,144,000
97,799,000
104,955,000
117,823,000
157,418,000
145,177,000
140,857,000
177,534,000
172,205,000
202,573,000
195,711,000
138,632,000
107,239,000
72,500,000
53,638,000
60,410,000
58,302,000
63,898,000
66,770,000
62,750,000
50,427,000
28,912,000
10,698,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.